KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.

Address: International Agency for Research on Cancer (IARC), Lyon, France.; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom. [email protected] [email protected].; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, the Netherlands.; Department of Public Health, Section for Epidemiology, Aarhus University, Denmark.; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands.; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; CESP, Faculté de Médecine, Université Paris-Sud, Faculté de médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.; Gustave Roussy, Villejuif, France.; CESP, Faculté de Médecine, Université Paris-Sud, Faculté de médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.; Gustave Roussy, Villejuif, France.; Laboratoire de Mathématiques Appliquées MAP5 (UMR CNRS 8145), Université Paris Descartes, Paris, France.; Hellenic Health Foundation, Athens, Greece.; Hellenic Health Foundation, Athens, Greece.; Department of Clinical Sciences and Community Health Università degli Studi di Milano, Milan, Italy.; Hellenic Health Foundation, Athens, Greece.; 2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Haidari, Greece.; Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute, ISPO, Florence, Italy.; Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Dipartimento Di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Catatlà d'Oncologia, L'Hospitalet de Llobregat, Spain.; Public Health Directorate, Asturias, Spain.; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford.; Department of Medicine, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, Massachusetts.; Department of Medicine, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. [email protected] [email protected].